MX392586B - Derivados de la espiropiperidina. - Google Patents

Derivados de la espiropiperidina.

Info

Publication number
MX392586B
MX392586B MX2019006920A MX2019006920A MX392586B MX 392586 B MX392586 B MX 392586B MX 2019006920 A MX2019006920 A MX 2019006920A MX 2019006920 A MX2019006920 A MX 2019006920A MX 392586 B MX392586 B MX 392586B
Authority
MX
Mexico
Prior art keywords
compounds
spiropiperidine
fatty acid
methods
acid synthase
Prior art date
Application number
MX2019006920A
Other languages
English (en)
Spanish (es)
Other versions
MX2019006920A (es
Inventor
Allison L Zulli
Craig A Zificsak
David B Whitman
Melody Mcwherter
Robert L Hudkins
Original Assignee
89Bio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 89Bio Ltd filed Critical 89Bio Ltd
Publication of MX2019006920A publication Critical patent/MX2019006920A/es
Publication of MX392586B publication Critical patent/MX392586B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2019006920A 2016-12-14 2017-12-14 Derivados de la espiropiperidina. MX392586B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662434167P 2016-12-14 2016-12-14
PCT/US2017/066422 WO2018112204A1 (en) 2016-12-14 2017-12-14 Spiropiperidine derivatives

Publications (2)

Publication Number Publication Date
MX2019006920A MX2019006920A (es) 2019-11-28
MX392586B true MX392586B (es) 2025-03-24

Family

ID=62559235

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019006920A MX392586B (es) 2016-12-14 2017-12-14 Derivados de la espiropiperidina.

Country Status (7)

Country Link
US (3) US11046707B2 (enExample)
EP (1) EP3554637A4 (enExample)
JP (2) JP7162591B2 (enExample)
CA (1) CA3046805A1 (enExample)
IL (1) IL267145B (enExample)
MX (1) MX392586B (enExample)
WO (1) WO2018112204A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2594188B (en) 2016-04-08 2022-02-09 Phillip Chevalier John Latching systems for latching movable panels
JP7162591B2 (ja) * 2016-12-14 2022-10-28 エイティナイン バイオ リミテッド スピロピペリジン誘導体
HU231333B1 (hu) * 2018-07-13 2023-01-28 Richter Gedeon Nyrt Spirokromán származékok
HU231414B1 (hu) 2018-07-13 2023-08-28 Richter Gedeon Nyrt. Tiadiazin származékok
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
CN113793910B (zh) * 2021-10-22 2024-11-26 浙江华显光电科技有限公司 有机光电器件及包含其的显示或照明装置

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08506817A (ja) 1993-02-12 1996-07-23 メルク エンド カンパニー インコーポレーテッド スピロ（２ｈ−１−ベンゾピラン−２，４′−ピペリジン）クラス▲ｉｉｉ▼抗不整脈薬
RU2422446C2 (ru) 2005-07-19 2011-06-27 Мерк Шарп Энд Домэ Корп. Производные спирохроманона в качестве ингибиторов ацетил коэнзим а карбоксилазы (асс)
TW200804393A (en) 2005-11-14 2008-01-16 Solvay Pharm Gmbh Novel N-sulfamoyl-N'-benzopyranpiperidines for medical use
ES2356841T3 (es) 2005-11-14 2011-04-13 Abbott Products Gmbh N-sulfamoil-n-benzopiranpiperidinas en calidad de inhibidores de anhidrasas carbónicas.
CA2674530C (en) 2007-01-12 2014-09-16 Banyu Pharmaceutical Co., Ltd. Spirochromanon derivatives
PE20081559A1 (es) * 2007-01-12 2008-11-20 Merck & Co Inc DERIVADOS DE ESPIROCROMANONA SUSTITUIDOS COMO INHIBIDORES DE ACETIL CoA CARBOXILASA
MX2010008375A (es) * 2008-01-30 2011-03-04 Cephalon Inc Star Derivados de piperidina espirocíclicos substituidos como ligandos de receptores de histamina-3 (h3).
CA2729412A1 (en) * 2008-07-04 2010-01-07 Banyu Pharmaceutical Co., Ltd. Novel spirochromanone carboxylic acids
WO2012161119A1 (ja) * 2011-05-20 2012-11-29 興和株式会社 新規なスピロピペリジン誘導体及びこれを含有する医薬
CN103304571B (zh) * 2012-03-06 2018-02-16 凯惠科技发展(上海)有限公司 螺环化合物、其制备方法、中间体、药物组合物和应用
JP2019531624A (ja) 2016-08-10 2019-10-31 アイディーエーシー ホールディングス インコーポレイテッド 次世代無線システムに対する空間変調
JP7162591B2 (ja) * 2016-12-14 2022-10-28 エイティナイン バイオ リミテッド スピロピペリジン誘導体

Also Published As

Publication number Publication date
JP2020511412A (ja) 2020-04-16
US11878982B2 (en) 2024-01-23
EP3554637A4 (en) 2020-05-20
EP3554637A1 (en) 2019-10-23
US20200031840A1 (en) 2020-01-30
WO2018112204A1 (en) 2018-06-21
US20210284651A1 (en) 2021-09-16
CA3046805A1 (en) 2018-06-21
JP7162591B2 (ja) 2022-10-28
US12448392B2 (en) 2025-10-21
US20240166661A1 (en) 2024-05-23
MX2019006920A (es) 2019-11-28
IL267145A (en) 2019-08-29
US11046707B2 (en) 2021-06-29
JP2022166192A (ja) 2022-11-01
IL267145B (en) 2022-01-01

Similar Documents

Publication Publication Date Title
PH12017502331A1 (en) 1,4-substituted piperidine derivatives
MX392586B (es) Derivados de la espiropiperidina.
MX379846B (es) Derivados de 4-bencil y 4-benzoil piperidina sustituidos.
EA201790246A1 (ru) Гетероциклические карбоновые кислоты в качестве активаторов растворимой гуанилатциклазы
EA201991399A1 (ru) Аминотриазолопиридиновые соединения и их применение в лечении рака
MX380122B (es) Derivado benzofurano, su metodo de preparacion, y sus usos en medicinas.
PH12017501191B1 (en) Quinazoline derivatives used to treat hiv
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
MX2021009806A (es) Ésteres de ácidos grasos de cadena media de beta-hidroxibutirato y butanodiol y composiciones y métodos para usar los mismos.
PH12016501977A1 (en) 2-AMINO-6-METHYL-4,4a,5,6-TETRAHYDROPYRANO[3,4-d][1,3]THIAZIN-8a(8H)-YL-1,3-THIAZOL-4-YL AMIDES
EA201500298A1 (ru) Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы
EA201692003A1 (ru) Макроциклические производные пиримидина
EA201692000A1 (ru) Макроциклические производные пиридина
PH12017500841A1 (en) 2-amino-6-(difluoromethyl)- 5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as bace1 inhibitors
EA201791259A1 (ru) Производные пиперидина в качестве ингибиторов hdac1/2
EA201591406A1 (ru) C-19 модифицированные тритерпеноиды с ингибиторной активностью созревания вич
EA201990678A1 (ru) Гетероарилкарбоксамидные соединения в качестве ингибиторов ripk2
PH12019501362A1 (en) Polymorphs
CY1121650T1 (el) Αναστολεις συνθασης αλδοστερονης
MX378591B (es) Intermedios para la sintesis de derivados de acido biliar, en particular, de acido obeticolico
MX377919B (es) Composiciones farmaceuticas solidas que comprenden derivados de biopterina y usos de tales composiciones.
EA201791396A1 (ru) ПРОИЗВОДНЫЕ ИМИДАЗОПИРИДАЗИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3Kβ